0001209191-19-013718.txt : 20190226
0001209191-19-013718.hdr.sgml : 20190226
20190226181630
ACCESSION NUMBER: 0001209191-19-013718
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190222
FILED AS OF DATE: 20190226
DATE AS OF CHANGE: 20190226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morris Charles Q
CENTRAL INDEX KEY: 0001489966
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35726
FILM NUMBER: 19634951
MAIL ADDRESS:
STREET 1: C/O IMMUNOGEN, INC.
STREET 2: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Radius Health, Inc.
CENTRAL INDEX KEY: 0001428522
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 800145732
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ATTN: CHIEF FINANCIAL OFFICER
STREET 2: 950 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-551-4000
MAIL ADDRESS:
STREET 1: ATTN: CHIEF FINANCIAL OFFICER
STREET 2: 950 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: MPM ACQUISITION CORP
DATE OF NAME CHANGE: 20080228
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-22
0
0001428522
Radius Health, Inc.
RDUS
0001489966
Morris Charles Q
C/O RADIUS HEALTH, INC.
950 WINTER STREET
WALTHAM
MA
02451
0
1
0
0
Chief Medical Officer
Common Stock
2019-02-22
4
A
0
15000
A
15000
D
Stock Option (Right to Buy)
19.18
2019-02-22
4
A
0
55000
0.00
A
2029-02-22
Common Stock
55000
55000
D
The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in four substantially equal annual installments on each of the first four anniversaries of the grant date of February 22, 2019, subject to continued service with RDUS through such dates.
25% of the shares subject to the stock option shall vest on February 22, 2020, and the remaining shares shall vest in substantially equal monthly
installments over the following three years, subject to continued service with RDUS through such dates.
/s/ Brent Hatzis-Schoch, as Attorney-in-Fact
2019-02-26